LifeScience
Merck and Abbisko Report Positive Phase III Results for Pimicotinib in TGCT Across Asia, Europe, and North America
Phase III MANEUVER study met primary endpoint, with an objective response rate at week 25 of 54.0% for pimicotinib versus 3.2% for placebo (p<0.0001) ...
November 21, 2024 | News
Singleron Biotechnologies Partners with TOMY Digital Biology to Expand Single Cell Analysis Solutions in Japan
Singleron Biotechnologies, a leader in single cell analysis solutions, has announced a new distributor partnership with TOMY Digital Biology Co., Ltd. Unde...
November 20, 2024 | News
Acepodia Secures FDA IND Clearance for ACE1831, Pioneering Gamma Delta T Cell Therapy in Autoimmune Disease
IND clearance paves the way for Acepodia to enter the clinic for the first time with its autoimmune program ACE1831 is an allogeneic gamma delta T...
November 18, 2024 | News
Medidata and Bioforum Expand Partnership to Enhance AI-Driven Clinical Trials for Biotech Clients
-Medidata, a Dassault Systèmes brand and a leading provider of clinical trial solutions for the life sciences industry announced a new corporate agr...
November 18, 2024 | News
Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
In an exclusive interview with BioPharma APAC, Pam Cheng, Executive Vice President of Global Operations & IT and Chief Sustainability Officer at AstraZ...
November 15, 2024 | Interview
Transgene and NEC Unveil Positive 24-Month Data for TG4050 Cancer Vaccine in Adjuvant Treatment of Head and Neck Cancer at SITC 2024
Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, and NEC Cor...
November 14, 2024 | News
Chime Biologics and Waterstone Pharmaceuticals Forge Strategic Alliance to Deliver Integrated Solutions for Global ADC Industry
Chime Biologics and Waterstone Pharmaceuticals announce a strategic partnership to provide integrated services for the global Antibody-Drug Conjugate (AD...
November 13, 2024 | News
Zymo Research Files Antitrust Counterclaims Against Qiagen, Alleging Misuse of Litigation to Stifle Innovation
Zymo Research Corporation (Zymo Research), a leader in innovative life science solutions, announced today that it has filed claims in the United District C...
November 13, 2024 | News
GenScript Expands Global Footprint with New Operations and Logistics Hub in Sydney, Australia
GenScript Biotech Corporation ("GenScript"), a global leader in life sciences services and products, has announced the establishment of new operations site...
November 12, 2024 | News
BioIVT and KRISHGEN BioSystems Forge Exclusive Agreement to Expand Access to High-Quality Biospecimen Solutions Across South Asia
-BioIVT, a global research partner and biospecimen solutions provider for drug and diagnostic development, announced an exclusive agreement* with KRI...
November 07, 2024 | News
Duoning Biotech and Branca Bunús Forge Strategic Partnership to Drive Innovation in Transfection Reagents for Biopharma
Duoning Biotechnology Group ("Duoning") announced a strategic partnership agreement with Branca Bunús Ltd. ("Branca Bunús"). Under this agree...
November 06, 2024 | News
Leica Biosystems and Cell Signaling Technology Join Forces to Streamline Spatial Biology Research with SignalStar™ Multiplex IHC on BOND RX
Fully automated SignalStar™ Multiplex IHC protocol on the BOND RX by Leica Biosystems eliminates hands-on time for streamlined image generation ...
November 05, 2024 | News
Teijin and Hilleman Laboratories Forge Strategic CDMO Partnership to Advance Cell and Gene Therapy in Asia-Pacific
Teijin Limited and Hilleman Laboratories, a biotechnology company based in Singapore, announced the signing of a Memorandum of Understanding...
October 31, 2024 | News
I Peace, Inc. Introduces HLA-Homozygous iPSC Line to Boost Compatibility and Accessibility in Allogenic Cell Therapies
I Peace, Inc., a leading GMP cell contract development and manufacturing organization (CDMO) specializing in induced pluripotent stem cells (iPSCs) and iPS...
October 30, 2024 | News
Most Read
- Pioneering Precision: Top 15 Clinical and Lab Diagnostic Companies to Watch in 2025
- 2025 Pharma and Medical Device Trends for Manufacturing Leaders
- 25 High-Value Drugs Losing Patent Protection in 2025: What It Means for Healthcare
- BioPharma Trends 2025: 25 Key Insights Shaping Asia Pacific's Future
- Driving Oncology Forward: 25 Companies Redefining Antibody-Drug Conjugates (ADCs) in 2025
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Top Management Shakeups of 2024: Redefining Pharma, Biopharma, and Biotech Leadership
- James Park Joins South Korean LOTTE BIOLOGICS as New CEO to Lead Global Expansion
- Australia Takes the Lead: Moderna Opens Southern Hemisphere’s First mRNA Manufacturing Facility in Victoria
- Eli Lilly Announces $3 Billion Expansion in Wisconsin to Boost Global Medicine Production
- Ngee Ann Polytechnic Partners with Merck Singapore to Elevate Biopharmaceutical Education
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Life Sciences CEOs Bet Big on AI and Workforce Growth Despite Economic and Industry Headwinds
News
